Willow Gabafen 100mg
Willow Gabafen 100mg provides 100 mg of Aminophenylbutyric Acid HCl per capsule in a convenient single-ingredient formula designed for occasional use as directed by your healthcare practitioner.
R237.00
Willow Gabafen 100mg contains 100 mg of Aminophenylbutyric Acid HCl per capsule in a simple, single-ingredient formulation.
This convenient capsule supplement is intended for adults seeking targeted nutritional supplementation under the guidance of a healthcare practitioner. The easy-to-take capsule format makes it suitable for occasional use when required.
Key Benefits
- Provides 100 mg of Aminophenylbutyric Acid HCl per capsule
- Single-ingredient formula
- Convenient capsule format
- Easy to incorporate into your wellness routine
- Suitable for occasional use as directed by your healthcare practitioner
Why Choose Willow Gabafen 100mg?
- High-quality single-ingredient formulation
- Convenient once-daily dosing when required
- Easy-to-swallow capsules
- Trusted Willow quality
Key Ingredient
Aminophenylbutyric Acid HCl
A specialised amino acid derivative supplied in a convenient capsule for nutritional supplementation.
Ingredients
- Aminophenylbutyric Acid HCl – 100 mg
Directions for Use
Take 1 capsule on an empty stomach before bedtime when necessary, or as directed by your healthcare practitioner.
Suitable For
- Adults
- Occasional nutritional supplementation
- Use under the guidance of a healthcare practitioner
Warnings
- Consult your healthcare practitioner before use if you are pregnant, breastfeeding, taking medication or have a medical condition.
- May cause drowsiness. Do not drive, operate machinery or consume alcohol after taking this product.
- Do not exceed the recommended dosage.
- Keep out of reach of children.
- Food supplements should not replace a varied, balanced diet and healthy lifestyle.
Storage
Store in a cool, dry place away from direct sunlight.
Product Information
- Brand: Willow
- Product: Gabafen 100mg
- Size: 60 Capsules
- Capsule Form





Reviews
There are no reviews yet.